Corcept Therapeutics, Inc. (CORT)
35.18
+0.36
(+1.03%)
USD |
NASDAQ |
Feb 23, 12:22
Corcept Therapeutics EPS Diluted (Quarterly) : 0.1621 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.9442 |
| United Therapeutics Corp. | 7.161 |
| Harrow, Inc. | 0.0262 |
| Ultragenyx Pharmaceutical, Inc. | -1.291 |
| Amneal Pharmaceuticals, Inc. | 0.0073 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.36M |
| Revenue (Quarterly) | 207.64M |
| Total Expenses (Quarterly) | 188.28M |
| Enterprise Value | 3.247B |
| Gross Profit Margin (Quarterly) | 97.79% |
| Profit Margin (Quarterly) | 9.32% |
| Earnings Yield | 2.49% |
| Operating Earnings Yield | 1.56% |
| Normalized Earnings Yield | 2.488 |